Article info
PDFLetter
Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19
- Correspondence to Professor Athanasios G Tzioufas, Department of Pathophysiology, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, 11527, Greece; agtzi{at}med.uoa.gr
Citation
Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19
Publication history
- Received May 19, 2020
- Revised June 12, 2020
- Accepted June 12, 2020
- First published June 24, 2020.
Online issue publication
November 13, 2020
Article Versions
- Previous version (24 June 2020).
- You are viewing the most recent version of this article.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage